These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 34489334)

  • 1. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma.
    Wang Z; He L; Li W; Xu C; Zhang J; Wang D; Dou K; Zhuang R; Jin B; Zhang W; Hao Q; Zhang K; Zhang W; Wang S; Gao Y; Gu J; Shang L; Tan Z; Su H; Zhang Y; Zhang C; Li M
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34489334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
    Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
    J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX12 Facilitates Hepatocellular Carcinoma Progression and Metastasis through Promoting Regulatory T-Cells Infiltration and Immunosuppression.
    Luo X; Huang W; Li S; Sun M; Hu D; Jiang J; Zhang Z; Wang Y; Wang Y; Zhang J; Wu Z; Ji X; Liu D; Chen X; Zhang B; Liang H; Li Y; Liu B; Wang S; Xu X; Nie Y; Wu K; Fan D; Xia L
    Adv Sci (Weinh); 2024 Sep; 11(36):e2310304. PubMed ID: 39072947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.
    Chew V; Lai L; Pan L; Lim CJ; Li J; Ong R; Chua C; Leong JY; Lim KH; Toh HC; Lee SY; Chan CY; Goh BKP; Chung A; Chow PKH; Albani S
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5900-E5909. PubMed ID: 28674001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Microenvironment-Responsive Nanocapsule Delivery CRISPR/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma Carcinoma.
    He L; Li Z; Su D; Du H; Zhang K; Zhang W; Wang S; Xie F; Qiu Y; Ma S; Shi G; Yu D; Lei X; Li W; Li M; Wang Z; Gu J; Zhang Y
    Adv Sci (Weinh); 2024 Jul; 11(26):e2403858. PubMed ID: 38704691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of peripheral and intratumoral regulatory T-cells in hepatocellular carcinoma: a case-control study.
    Thakur S; Singla A; Chawla Y; Rajwanshi A; Kalra N; Arora SK
    Indian J Pathol Microbiol; 2011; 54(3):448-53. PubMed ID: 21934201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma.
    Shen X; Li N; Li H; Zhang T; Wang F; Li Q
    J Cancer Res Clin Oncol; 2010 Nov; 136(11):1745-54. PubMed ID: 20221638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy.
    Du G; Dou C; Sun P; Wang S; Liu J; Ma L
    Front Immunol; 2024; 15():1431211. PubMed ID: 39136031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients.
    Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Cai XY; He HW; Jin JJ; Cheng YF; Fan J; Sun J; Qiu SJ
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1555-64. PubMed ID: 23517245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity.
    Chen ML; Yan BS; Lu WC; Chen MH; Yu SL; Yang PC; Cheng AL
    Int J Cancer; 2014 Jan; 134(2):319-31. PubMed ID: 23818246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmacytoid dendritic cells recruited by HIF-1α/eADO/ADORA1 signaling induce immunosuppression in hepatocellular carcinoma.
    Pang L; Ng KT; Liu J; Yeung WO; Zhu J; Chiu TS; Liu H; Chen Z; Lo CM; Man K
    Cancer Lett; 2021 Dec; 522():80-92. PubMed ID: 34536555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
    Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
    Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells.
    Koido S; Homma S; Hara E; Mitsunaga M; Namiki Y; Takahara A; Nagasaki E; Komita H; Sagawa Y; Ohkusa T; Fujise K; Gong J; Tajiri H
    J Transl Med; 2008 Sep; 6():51. PubMed ID: 18793383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production.
    Myojin Y; Hikita H; Sugiyama M; Sasaki Y; Fukumoto K; Sakane S; Makino Y; Takemura N; Yamada R; Shigekawa M; Kodama T; Sakamori R; Kobayashi S; Tatsumi T; Suemizu H; Eguchi H; Kokudo N; Mizokami M; Takehara T
    Gastroenterology; 2021 Apr; 160(5):1741-1754.e16. PubMed ID: 33346004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased frequency of Foxp3+ regulatory T cells in mice with hepatocellular carcinoma.
    Du Y; Chen X; Huang ZM; Ye XH; Niu Q
    Asian Pac J Cancer Prev; 2012; 13(8):3815-9. PubMed ID: 23098476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.
    Lim CJ; Lee YH; Pan L; Lai L; Chua C; Wasser M; Lim TKH; Yeong J; Toh HC; Lee SY; Chan CY; Goh BK; Chung A; Heikenwälder M; Ng IO; Chow P; Albani S; Chew V
    Gut; 2019 May; 68(5):916-927. PubMed ID: 29970455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solanine Inhibits Immune Escape Mediated by Hepatoma Treg Cells via the TGF
    Gao J; Ying Y; Wang J; Cui Y
    Biomed Res Int; 2020; 2020():9749631. PubMed ID: 33204731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA4 downregulation enhances CCL20-mediated immunosuppression in hepatocellular carcinoma.
    Nasir NJM; Chuah S; Shuen T; Prawira A; Ba R; Lim MC; Chua J; Nguyen PHD; Lim CJ; Wasser M; Hazirah SN; Lim TKH; Leow WQ; Loh TJ; Wan WK; Pang YH; Soon G; Cheow PC; Kam JH; Iyer S; Kow A; Dan YY; Bonney GK; Chung A; Goh BKP; Chow PKH; Albani S; Zhai W; Ouyang JF; Toh HC; Chew V
    Hepatol Commun; 2024 Sep; 8(9):. PubMed ID: 39167427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPROt maintains T cell immunity in the microenvironment of hepatocellular carcinoma.
    Hou J; Deng L; Zhuo H; Lin Z; Chen Y; Jiang R; Chen D; Zhang X; Huang X; Sun B
    J Mol Cell Biol; 2015 Aug; 7(4):338-50. PubMed ID: 26117839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.